NS5331_Assessment4_Audio_EVERSON

To briefly introduce this project plan, it has been identified that intravascular devices, also called IBDs, cause over 3,500 bloodstream infections, also known as BSIs, annually, leading to a mortality rate of over 10% and often results in significant morbidity. In alignment with the National Model Clinical Governance Framework, a quality improvement initiative has been developed to decrease the rate of IBD-associated BSIs. In the clinical setting, by 20% within six months. The five components of the National Model Clinical Governance Framework have been thoughtfully interwined within this quality improvement initiative, the first being governance, leadership and culture. As defined by the framework, this component relates to the establishment of and participation in corporate and clinical governance systems to improve the safety and quality of healthcare for patients. This is clearly reflected within the quality improvement initiative through the identification of an opportunity for improvement, development of a goal and plan that is specific, measurable, achievable, relevant and timely, as well as establishing the multidisciplinary team who will participate in and are accountable to improving patient safety. The second component, patient safety and quality improvement systems, outlines the need for these systems to be integrated with governance processes to actively manage and improve the safety and quality of healthcare for patients. This quality improvement initiative incorporates this component through the demonstration of ensuring identified opportunities, such as the need to decrease IBD-related BSIs, are raised, reported and systematically monitored through the use of accurate documentation, auditing and development of alert systems to improve safety and quality for patients. The third component of the National Clinical Governance Framework is clinical performance and effectiveness, which highlights the need for clinicians to have the right qualifications, skills and supervision to provide safe, high-quality care to patients. This component has been incorporated in the initiative by identifying and developing change ideas to improve training and education specific to preventing IBD-associated BSIs. The next component of the framework, safe environment for the delivery of care, has been upheld in this project plan by not only maintaining vigilance for opportunities to improve the healthcare environment, including the improvement of IBD use and management, but also coordinating and overseeing the planning and development of the quality improvement project itself, which aims to improve and promote a safer and higher-quality environment for the delivery of healthcare. The final component of the National Clinical Governance Framework is partnering with consumers. This component is dedicated to the design and use of systems to support patients, carers and families to be partners in healthcare planning, design, measurement and evaluation. By developing and providing leaflets for consumers that outline risks of prevention of IBD-associated BSIs prior to the insertion of an IBD, performing bedside handover that includes the patient and displaying highly visible audit findings of risks associated with IBDs, the consumer is enabled and encouraged to advocate and make informed decisions about their healthcare and in turn assist in the prevention of IBD-associated BSIs. Changing focus now to the careful selection of the primary and secondary drivers incorporated in this quality improvement initiative, studies have identified that improving training and education is paramount in preventing IBD-associated BSIs due to its significant impact on patient safety and healthcare outcomes. Finding gaps in knowledge and skills within the team can assist the development of evidence-based education and training that is highly relevant to the clinicians and in turn effectively reduce the incidences of IBD-associated BSIs. In addition, the improvement of safety and quality systems used for IBD management, including the accurate and timely documentation and transparency of data, is crucial in preventing IBD-associated BSIs. These systems provide a foundation for effective infection prevention strategies and facilitate continuous monitoring and improvement, therefore enabling healthcare providers to effectively prevent IBD-associated BSIs and enhance patient safety. Lastly, improving communication between all team members through effective clinical handover and partnering with consumers plays a vital role in preventing IBD-associated BSIs by enhancing coordination, collaboration and patient engagement. Effective communication ensures accurate information transfer, seamless care transitions and shared decision making. Engaging and educating patients empowers them to actively participate in infection prevention while continuous feedback and improvement fosters a culture of effective communication. By enhancing communication strategies, healthcare providers can effectively prevent IBD-associated BSIs. To conclude this presentation, clinical governance is an indispensable framework that ensures accountability, quality and safety in healthcare. It encompasses setting standards, monitoring performance, managing risks, supporting professional development, engaging patients and promoting continuous improvement to ensure healthcare organisations prioritise quality and safety in all aspects of healthcare delivery. The clinical governance framework acts as a guide for healthcare professionals to continuously enhance their practices, leading to improved patient outcomes and a culture of safety and excellence in healthcare.